TLR3 activation enhances sorafenib-antitumor effect in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathways
Qiangbo Zhang(Qilu Hospital of Shandong University), Enyu Liu(Yan'an University)
Cited by 0
Related Papers
Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma
|PLoS ONE|2013|60
TLR3 activation enhances antitumor effects of sorafenib in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathways
|Scientific Reports|2024|2
QTL Analysis for Rice Quality-Related Traits and Fine Mapping of qWCR3
|International Journal of Molecular Sciences|2024|1